Biosino Bio-Technology and Science (HKSE:08247) EPS (Basic): HK$-0.39 (TTM As of Dec. 2025)


HKSE:08247 Biosino Bio-Technology and Science Inc HKSE:08247
32 GF Score
Price HK$2.89
GF Value HK$0.45
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Biosino Bio-Technology and Science EPS (Basic)?

Biosino Bio-Technology and Science HKSE:08247 +1.05% 32 EPS (Basic) is HK$-0.39 as of Dec. 2025. GuruFocus rates HKSE:08247 with a GF Score™ of 32/100 and a GF Value™ of HK$0.45 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Biosino Bio-Technology and Science's basic earnings per share (Basic EPS) for the six months ended in Dec. 2025 was HK$-0.25. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-0.39.

Biosino Bio-Technology and Science's EPS (Diluted) for the six months ended in Dec. 2025 was HK$-0.25. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-0.39.

Biosino Bio-Technology and Science's EPS without NRI for the six months ended in Dec. 2025 was HK$-0.25. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was -0.39.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Biosino Bio-Technology and Science's highest 3-Year average EPS without NRI Growth Rate was 20.60% per year. The lowest was -169.90% per year. And the median was -9.80% per year.

Biosino Bio-Technology and Science  (HKSE:08247) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Biosino Bio-Technology and Science EPS (Basic) Related Terms

Biosino Bio-Technology and Science EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Biosino Bio-Technology and Science's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biosino Bio-Technology and Science EPS (Basic) Chart

Biosino Bio-Technology and Science Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.01 0.06 -0.09 -0.31 -0.39

Biosino Bio-Technology and Science Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.05 -0.10 -0.22 -0.14 -0.25
HKSE:08247
32GF Score
Biosino Bio-Technology and Science Inc HKSE:08247
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biosino Bio-Technology and Science EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Biosino Bio-Technology and Science's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-56.498-0)/144.707
=-0.39

Biosino Bio-Technology and Science's Basic EPS for the quarter that ended in Dec. 2025 is calculated as

Basic EPS (Q: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-36.639-0)/144.707
=-0.25

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-0.39

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of HK$-0.39 mean?
Biosino Bio-Technology and Science (HKSE:08247) has a EPS (Basic) of HK$-0.39 as of Dec. 2025. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Biosino Bio-Technology and Science and its competitors.
Is Biosino Bio-Technology and Science's EPS (Basic) too high?
Biosino Bio-Technology and Science's current EPS (Basic) is HK$-0.39. Overall, Biosino Bio-Technology and Science has a GF Score™ of 32/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Biosino Bio-Technology and Science's EPS (Basic) compare to TMO and DHR?
Biosino Bio-Technology and Science's EPS (Basic) of HK$-0.39 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Medical Diagnostics & Research company?
A good EPS (Basic) depends on the Medical Diagnostics & Research industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Biosino Bio-Technology and Science and its competitors. Biosino Bio-Technology and Science's current EPS (Basic) is HK$-0.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biosino Bio-Technology and Science stock overvalued right now?
Based on GuruFocus' analysis, Biosino Bio-Technology and Science (HKSE:08247) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.45, compared to a current price of HK$2.89 — trading 542.2% above its estimated fair value. The current EPS (Basic) is HK$-0.39. Biosino Bio-Technology and Science's overall GF Score™ is 32/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Biosino Bio-Technology and Science (HKSE:08247), the current EPS (Basic) is HK$-0.39 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Biosino Bio-Technology and Science (HKSE:08247) Overvalued in 2026?

Based on GuruFocus' analysis, Biosino Bio-Technology and Science stock appears to be overvalued. The current stock price of HK$2.89 is trading 542.2% above its estimated GF Value™ of HK$0.45. GuruFocus considers Biosino Bio-Technology and Science to be Significantly Overvalued.

Key valuation signals for HKSE:08247:

  • EPS (Basic): HK$-0.39
  • GF Value™: HK$0.45 vs. price of HK$2.89 (542.2% above fair value)
  • GF Score™: 32/100 with 6 warning signs

No single metric tells the full story. See the HKSE:08247 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Biosino Bio-Technology and Science Business Description

Address No. 27 Chaoqian Road, Science and Technology Industrial Park, Changping District, Beijing, CHN, 102200
Biosino Bio-Technology and Science Inc is engaged in the manufacture, sale, and distribution of IVD reagent products. The company operates in a single segment, the in-vitro diagnostic products segment, which manufactures, sells, and distributes a variety of mono/double diagnostic products. Geographically, it generates the majority of the revenue from Mainland China.
32GF Score

Get the complete analysis for HKSE:08247

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$2.89
Price
HK$0.45
GF Value